ALKEM Alkem Laboratories Ltd Disposals and divestitures Announcement 2024 - Business Transfer Approval Alkem Laboratories Ltd has approved the transfer of its trade generics business to its subsidiary Alkem Wellness Ltd for a minimum consideration of Rs. 750 crores, effective by March 31, 2025. This trade generics business generated revenue of about Rs. 1,783.8 crores in FY 2023-2024..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Alkem Laboratories Ltd